Page last updated: 2024-08-21

oxazoles and zolmitriptan

oxazoles has been researched along with zolmitriptan in 111 studies

Research

Studies (111)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	93 (83.78)	18.2507
2000's	16 (14.41)	29.6817
2010's	2 (1.80)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cox, RC; Ferrari, MD; Jones, D; Klein, KB; Visser, WH	1
Ferrari, MD	3
Earl, NL	1
Martin, GR	2
Geraud, GE	1
Dowson, A	2
Edmeads, JG	1
Bendtsen, L; Daugaard, D; Dixon, R; Gibbens, M; Langemark, M; Lassen, LH; Olesen, J; Thomsen, LL	1
Churchus, R; On, N; Phillips, S; Posner, J; Rolan, P; Seaber, E	1
Goadsby, PJ; Hoskin, KL	2
Goadsby, PJ; Olesen, J	1
Zagami, AS	1
Dowson, AJ	1
Dixon, R; Gibbens, M; Gillotin, C; Peck, RW; Posner, J	1
Barrett, VJ; Buckingham, J; Giles, H; Honey, AC; MacLennan, SJ; Martin, GR; Moncada, S; Prentice, DJ; Robertson, AD	1
Goadsby, PJ; Knight, YE	1
Chittick, G; Dixon, RM; Gibbens, M; Leavens, WJ; Liptrot, J; On, N; Pack, RW; Posner, J; Rolan, PE; Seaber, E	1
Goadsby, PJ	3
Schoenen, J	1
Dahlöf, C	1
Dixon, RM; Evans, DH; Meire, HB; On, N; Posner, J; Rolan, PE; Watt, H	1
Castro, ME; Pascual, J; Pazos, A	1
Cutrer, FM; Moskowitz, MA	1
Adelman, JU; Earl, NL; Elkind, AH; Kudrow, DB; Mathew, NT; Ramadan, NM; Rapoport, AM	1
Cady, RK; Earl, NL; Klapper, JA; Ramadan, NM; Saper, JR; Solomon, GD	1
Mathew, N	1
Dixon, R; Warrander, A	1
Rolan, P	1
Sawyer, J; Schoenen, J	1
Edmeads, JG; Millson, DS	1
Lipton, RB; Stewart, WF	1
Bagnis, C; Deray, G; Gillotin, C; Mamet, JP; Peck, RW	1
Dixon, R; Gillotin, CG; Layton, G; Peck, RW; Posner, J; Seaber, EJ; Weatherley, BC	1
Goadsby, PJ; Storer, RJ	1
Afra, J; Proietti-Cecchini, A; Schoenen, J	1
Layton, G; Peck, RW; Posner, J; Ridout, G; Seaber, EJ	1
Colpaert, FC; John, GW; Pagniez, F; Valentin, JP; Vieu, S	1
Arnold, G; Back, T; Dirnagl, U; Dreier, J; Einhäupl, KM; Gold, L; Reuter, U	1
Dixon, RM; Jackson, SH; Layton, GR; Peck, RW; Posner, J; Rolan, PE; Seaber, EJ; Weatherley, BC	1
Guanci, R; Lilley, LL	1
Cleary, EW; Huffman, CS; Polvino, WJ; Smith, DA; Watkins, S	1
Cleary, EW; Dilzer, SC; Huffman, CS; Lasseter, KC; Smith, DA; Watkins, S	1
Delvaux, M; Dixon, R; French, S; Kemp, J; Leclerc, V; Rautureau, J; Sellers, M	1
John, GW; Le Grand, B; Vié, B	1
Förderreuther, S; Straube, A; Werhahn, KJ	1
Dixon, R; Hughes, AM; Kemp, JV; Nairn, K; Sellers, M; Yates, RA	1
Allanson, J; Hefting, NR; Jonkman, JH; Peck, RW; Seaber, EJ; Smith, DA; Sollie, FA; van Lier, JJ; Wemer, J	1
Pascual, J	1
Leira, R; Noya, M	1
Morales Asín, F	1
Cambridge, D; MacLennan, SJ; Marston, C; Martin, GR; Whiting, MV	1
Cumberbatch, MJ; Hargreaves, RJ; Hill, RG	1
Lohman, JJ; van der Kuy, PH	1
Meijler, W	1
Gibbens, M; Lamb, RJ; Mercer, AJ; Posner, J; Rolan, PE	1
Monseu, G; Sternon, J	1
Diener, HC; Fritsche, G; Kazarawa, Z; Limmroth, V	1
Hopkins, B; McHarg, A; Melrose, H; Napier, C; Stewart, M; Wallis, R	1
Cummings, L; Dane, A; Dixon, R; Hughes, AM; Kemp, J; Yates, RA	1
Dixon, R; Engleman, K; Kemp, J; Ruckle, JL	1
Bard, JA; Branchek, T; Edvinsson, L; Longmore, J; Nilsson, T; Pantev, E; Shaw, D	1
Bungay, PJ; George, SE; Kemp, DM; Naylor, LH	1
Birk, KL; Cohen, AF; De Puy, ME; De Smet, M; Fisher, AL; Goldberg, MR; Musson, DG; Sterrett, A; Van Gerven, JM; Van Haarst, AD	1
Deleu, D; Hanssens, Y	2
Bhagwagar, Z; Cowen, PJ; Whale, R	1
Gunasekara, NS; Hills, C; Spencer, CM	1
Diener, HC; Limmroth, V	1
Buzzi, MG	1
Le Jeunne, C	1
Dixon, R	1
Butters, CJ; McKillop, D; Wild, MJ	1
Diener, HC; Dowson, AJ; Ferrari, M; Nappi, G; Tfelt-Hansen, P	1
Amelin, AV; Korenko, LA; Skoromets, AA	1
Bartlett, MG; Stewart, JT; Vishwanathan, K	1
Bomhof, MA; Donnan, GA; Dowson, AJ; Elkind, A; Fletcher, PE; Meloche, J; Millson, DS; Tepper, SJ	1
Edvinsson, L; Geraud, G; Korczyn, A; Mauskop, A; Pfaffenrath, V; Tuchman, M	1
Farkkila, M; Hering-Hanit, R; Mauskop, A; Rapoport, A; Warner, J	1
Logemann, CD; Rankin, LM	1
Millson, DS	1
Chalimoniuk, M; Stepień, A; Strosznajder, J	1
Ferrari, MD; Lamers, FP; Roon, KI; Sándor, PS; Schoenen, J; Schoonman, GG; van Dijk, JG	1
Nater, B; Regli, F	1
Peacock, JH; Vijayan, N	1
Chitra, R; Dennish, G; Gallagher, RM; Spierings, EL	1
Duckmanton, L	1
Bahra, A; Breen, SA; Gawel, MJ; Goadsby, PJ; Hardebo, JE; Millson, D	1
Diener, HC; Geraud, G; Olesen, J; Pfaffenrath, V; Sweet, R; Tfelt-Hansen, P; Zupping, R	1
Bjork, JM; Dougherty, DM; Marsh, DM; Moeller, FG; Swann, AC; Van de Kar, LD	1
John, GW; Le Grand, B; Panissié, A; Pauwels, PJ; Perez, M	1
Chernyshev, O; Gentry, P; Kailasam, J; Mathew, NT	1
de Tommaso, M; Guido, M; Libro, G; Puca, F; Sciruicchio, V	1
Bartleson, JD	1
Dixon, R; Nairn, K; Seaber, E; Yates, R	1
Dane, AL; Dixon, R; Kemp, JV; Nairn, K; Yates, R	1
Břicháč, J; Douša, M; Gibala, P; Klecán, O; Mandelová, Z; Pekárek, T; Rádl, S	1
Al-Huniti, N; Birmingham, B; Li, J; Lillieborg, S; Xu, H; Zhou, D; Zhou, W	1

Reviews

21 review(s) available for oxazoles and zolmitriptan

Article	Year
The clinical effectiveness of 311C90 in the acute treatment of migraine. European neurology, 1996, Volume: 36 Suppl 2 Topics: Double-Blind Method; Humans; Migraine Disorders; Multicenter Studies as Topic; Oxazoles; Oxazolidinones; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Tryptamines	1996
Clinical safety of 311C90: aggregated data from patients and volunteers to date. European neurology, 1996, Volume: 36 Suppl 2 Topics: Adult; Aged; Blood Pressure; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Reference Values; Serotonin Receptor Agonists; Tryptamines	1996
Inhibition of the trigemino-vascular system with 5-HT1D agonist drugs: selectively targeting additional sites of action. European neurology, 1996, Volume: 36 Suppl 2 Topics: Administration, Oral; Biological Availability; Cerebrovascular Circulation; Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Trigeminal Nerve; Tryptamines	1996
Emerging preclinical and clinical profile of 311C90: a poster review and discussion. European neurology, 1996, Volume: 36 Suppl 2 Topics: Animals; Central Nervous System; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Quality of Life; Serotonin Receptor Agonists; Tryptamines	1996
Increasing the options for effective migraine management. Neurology, 1997, Volume: 48, Issue:3 Suppl 3 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Ergotamine; Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Quality of Life; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	1997
311C90: increasing the options for therapy with effective acute antimigraine 5HT1B/1D receptor agonists. Neurology, 1997, Volume: 48, Issue:3 Suppl 3 Topics: Headache; Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Tryptamines	1997
Zolmitriptan. Introduction. Cephalalgia : an international journal of headache, 1997, Volume: 17 Suppl 18 Topics: Drug Interactions; Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	1997
Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine. Cephalalgia : an international journal of headache, 1997, Volume: 17 Suppl 18 Topics: Administration, Oral; Animals; Biological Availability; Drug Evaluation, Preclinical; Hemodynamics; Injections, Intravenous; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Tryptamines	1997
Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig, 311C90). Cephalalgia : an international journal of headache, 1997, Volume: 17 Suppl 18 Topics: Acetaminophen; Adolescent; Adult; Drug Interactions; Drug Therapy, Combination; Ergotamine; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Tryptamines	1997
Clinical applications of zolmitriptan (Zomig, 311C90). Cephalalgia : an international journal of headache, 1997, Volume: 17 Suppl 18 Topics: Acute Disease; Disabled Persons; Dose-Response Relationship, Drug; Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Recurrence; Serotonin Receptor Agonists; Tryptamines	1997
[Mechanism of action of zolmitriptan]. Neurologia (Barcelona, Spain), 1998, Volume: 13 Suppl 2 Topics: Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Receptors, Serotonin; Serotonin Receptor Agonists; Tryptamines	1998
[Clinical efficacy of zolmitriptan in migraine]. Neurologia (Barcelona, Spain), 1998, Volume: 13 Suppl 2 Topics: Adolescent; Adult; Aged; Humans; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	1998
[Safety profile of 311C90 (zolmitriptan)]. Neurologia (Barcelona, Spain), 1998, Volume: 13 Suppl 2 Topics: Dose-Response Relationship, Drug; Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Tryptamines	1998
Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents. Acta neurologica Belgica, 1999, Volume: 99, Issue:2 Topics: Acute Disease; Animals; Clinical Trials as Topic; Coronary Circulation; Coronary Vasospasm; Drug Design; Drug Interactions; Humans; Inactivation, Metabolic; Indoles; Meninges; Migraine Disorders; Molecular Structure; Nociceptors; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Pyrrolidines; Randomized Controlled Trials as Topic; Rats; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Recurrence; Serotonin Receptor Agonists; Structure-Activity Relationship; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Vasoconstrictor Agents	1999
Zolmitriptan: a review of its use in migraine. Drugs, 1999, Volume: 58, Issue:2 Topics: Age Factors; Clinical Trials as Topic; Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Time Factors; Tryptamines	1999
Acute management of migraine: triptans and beyond. Current opinion in neurology, 1999, Volume: 12, Issue:3 Topics: Humans; Indoles; Migraine Disorders; Oxazoles; Oxazolidinones; Piperidines; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	1999
[Zolmitriptan]. Presse medicale (Paris, France : 1983), 1999, Sep-25, Volume: 28, Issue:28 Topics: Drug Costs; Drug Interactions; Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Patient Selection; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	1999
The scientific basis of medication choice in symptomatic migraine treatment. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1999, Volume: 26 Suppl 3 Topics: Acute Disease; Choice Behavior; Dose-Response Relationship, Drug; Humans; Indoles; Migraine Disorders; Models, Biological; Oxazoles; Oxazolidinones; Piperidines; Serotonin Receptor Agonists; Severity of Illness Index; Sumatriptan; Triazoles; Tryptamines	1999
Newer intranasal migraine medications. American family physician, 2000, Jan-01, Volume: 61, Issue:1 Topics: Administration, Intranasal; Administration, Oral; Analgesics, Non-Narcotic; Clinical Trials as Topic; Dihydroergotamine; Half-Life; Humans; Indoles; Migraine Disorders; Oxazoles; Oxazolidinones; Piperidines; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines	2000
How effective are triptans in the treatment of episodic and chronic cluster headache. Italian journal of neurological sciences, 1999, Volume: 20, Issue:2 Suppl Topics: Chronic Disease; Cluster Headache; Humans; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	1999
Current and emerging second-generation triptans in acute migraine therapy: a comparative review. Journal of clinical pharmacology, 2000, Volume: 40, Issue:7 Topics: Acute Disease; Carbazoles; Humans; Indoles; Migraine Disorders; Oxazoles; Oxazolidinones; Piperidines; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Triazoles; Tryptamines	2000

Trials

41 trial(s) available for oxazoles and zolmitriptan

Article	Year
311C90, a new central and peripherally acting 5-HT1D receptor agonist in the acute oral treatment of migraine: a double-blind, placebo-controlled, dose-range finding study. Neurology, 1996, Volume: 46, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Pain Measurement; Placebos; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Tryptamines	1996
Evaluation of the long-term safety and efficacy of 311C90 in the treatment of migraine. European neurology, 1996, Volume: 36 Suppl 2 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Child; Drug Administration Schedule; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Tryptamines	1996
Can oral 311C90, a novel 5-HT1D agonist, prevent migraine headache when taken during an aura? European neurology, 1996, Volume: 36 Suppl 2 Topics: Administration, Oral; Adult; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Tryptamines; United Kingdom	1996
The tolerability and pharmacokinetics of the novel antimigraine compound 311C90 in healthy male volunteers. British journal of clinical pharmacology, 1996, Volume: 41, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Placebos; Reference Values; Serotonin Receptor Agonists; Tryptamines	1996
311C90: long-term efficacy and tolerability profile for the acute treatment of migraine. International 311C90 Long-Term Study Group. Neurology, 1997, Volume: 48, Issue:3 Suppl 3 Topics: Adolescent; Adult; Aged; Child; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Research Design; Serotonin Receptor Agonists; Time Factors; Tryptamines	1997
The pharmacokinetics and effects on blood pressure of multiple doses of the novel anti-migraine drug zolmitriptan (311C90) in healthy volunteers. British journal of clinical pharmacology, 1997, Volume: 43, Issue:3 Topics: Administration, Oral; Adult; Analysis of Variance; Blood Pressure; Cross-Over Studies; Double-Blind Method; Female; Heart Rate; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Tryptamines	1997
[Zolmitriptan: new perspectives in migraine therapy. Satellite symposium of the 11th Migraine Trust International Symposium, London, 10 September 1996]. Fortschritte der Neurologie-Psychiatrie, 1997, Volume: 65, Issue:2 Suppl Topics: Blood-Brain Barrier; Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Sumatriptan; Tryptamines	1997
The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90). British journal of clinical pharmacology, 1997, Volume: 43, Issue:6 Topics: Absorption; Administration, Oral; Adult; Analysis of Variance; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Chromatography, Liquid; Cross-Over Studies; Feces; Female; Half-Life; Humans; Indoleacetic Acids; Infusions, Intravenous; Male; Mass Spectrometry; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Sex Factors; Tryptamines	1997
Peripheral vascular effects and pharmacokinetics of the antimigraine compound, zolmitriptan, in combination with oral ergotamine in healthy volunteers. Cephalalgia : an international journal of headache, 1997, Volume: 17, Issue:6 Topics: Administration, Oral; Adult; Biological Availability; Blood Pressure; Caffeine; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Ergotamine; Female; Humans; Intestinal Absorption; Male; Oxazoles; Oxazolidinones; Pulse; Reference Values; Serotonin Receptor Agonists; Tryptamines; Vasoconstrictor Agents	1997
Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group. Neurology, 1997, Volume: 49, Issue:5 Topics: Acute Disease; Adolescent; Adult; Aged; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Recurrence; Serotonin Receptor Agonists; Tryptamines	1997
Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group. Neurology, 1997, Volume: 49, Issue:5 Topics: Acute Disease; Adolescent; Adult; Aged; Child; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Tryptamines	1997
Zolmitriptan (Zomig, 311C90), a novel dual central and peripheral 5HT1B/1D agonist: an overview of efficacy. Cephalalgia : an international journal of headache, 1997, Volume: 17 Suppl 18 Topics: Adolescent; Adult; Aged; Child; Dose-Response Relationship, Drug; Female; Humans; Menstruation; Middle Aged; Migraine Disorders; Nausea; Oxazoles; Oxazolidinones; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	1997
Tolerability profile of zolmitriptan (Zomig; 311C90), a novel dual central and peripherally acting 5HT1B/1D agonist. International clinical experience based on > 3000 subjects treated with zolmitriptan. Cephalalgia : an international journal of headache, 1997, Volume: 17 Suppl 18 Topics: Administration, Oral; Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Cardiovascular System; Child; Humans; Incidence; Middle Aged; Oxazoles; Oxazolidinones; Reference Values; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	1997
No need to adjust the dose of 311C90 (zolmitriptan), a novel anti-migraine treatment, in patients with renal failure not requiring dialysis. International journal of clinical pharmacology and therapeutics, 1997, Volume: 35, Issue:11 Topics: Adult; Aged; Area Under Curve; Blood Pressure; Electrocardiography; Female; Half-Life; Humans; Kidney Failure, Chronic; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Renal Dialysis; Serotonin Receptor Agonists; Tryptamines	1997
The interaction between propranolol and the novel antimigraine agent zolmitriptan (311C90). British journal of clinical pharmacology, 1997, Volume: 44, Issue:6 Topics: Adrenergic beta-Antagonists; Adult; Area Under Curve; Biotransformation; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Interactions; Electrocardiography; Female; Half-Life; Humans; Male; Oxazoles; Oxazolidinones; Propranolol; Serotonin Receptor Agonists; Tryptamines	1997
Intensity dependence of the cortical auditory evoked potentials as a surrogate marker of central nervous system serotonin transmission in man: demonstration of a central effect for the 5HT1B/1D agonist zolmitriptan (311C90, Zomig). Cephalalgia : an international journal of headache, 1997, Volume: 17, Issue:8 Topics: Adult; Cerebral Cortex; Dose-Response Relationship, Drug; Double-Blind Method; Evoked Potentials, Auditory; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Synaptic Transmission; Tryptamines	1997
The novel anti-migraine compound zolmitriptan (Zomig 311C90) has no clinically significant interactions with paracetamol or metoclopramide. European journal of clinical pharmacology, 1997, Volume: 53, Issue:3-4 Topics: Acetaminophen; Adult; Blood Pressure; Drug Interactions; Female; Humans; Male; Metoclopramide; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Tryptamines	1997
The pharmacodynamics and pharmacokinetics of the 5HT1B/1D-agonist zolmitriptan in healthy young and elderly men and women. Clinical pharmacology and therapeutics, 1998, Volume: 63, Issue:3 Topics: Adult; Age Factors; Aged; Blood Pressure; Central Nervous System; Double-Blind Method; Electrocardiography; Female; Half-Life; Heart Rate; Humans; Male; Oxazoles; Oxazolidinones; Reference Values; Serotonin Receptor Agonists; Sex Factors; Tryptamines	1998
The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study. The International 311C90 Long-term Study Group. Headache, 1998, Volume: 38, Issue:3 Topics: Adult; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Recurrence; Serotonin Receptor Agonists; Tryptamines	1998
Zolmitriptan (311C90) does not interact with fluoxetine in healthy volunteers. International journal of clinical pharmacology and therapeutics, 1998, Volume: 36, Issue:6 Topics: Adolescent; Adult; Cranial Sinuses; Cross-Over Studies; Dizziness; Drug Interactions; Drug Tolerance; Female; Fluoxetine; Humans; Intracranial Pressure; Male; Middle Aged; Nausea; Oxazoles; Oxazolidinones; Patient Compliance; Pharyngitis; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Tryptamines	1998
Pharmacokinetics and pharmacodynamics of zolmitriptan in patients with mild to moderate hypertension: a double-blind, placebo-controlled study. Journal of clinical pharmacology, 1998, Volume: 38, Issue:8 Topics: Area Under Curve; Blood Pressure; Cross-Over Studies; Diuretics; Double-Blind Method; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Sodium Chloride Symporter Inhibitors; Tryptamines	1998
Effect of hepatic impairment on the pharmacokinetics of zolmitriptan. Journal of clinical pharmacology, 1998, Volume: 38, Issue:8 Topics: Adult; Aged; Area Under Curve; Biotransformation; Blood Pressure; Female; Half-Life; Humans; Liver Diseases; Male; Middle Aged; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Tryptamines	1998
Effects of the antimigraine compound zolmitriptan ('Zomig') on psychomotor performance alone and in combination with diazepam in healthy volunteers. Cephalalgia : an international journal of headache, 1998, Volume: 18, Issue:7 Topics: Adult; Cross-Over Studies; Diazepam; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Oxazoles; Oxazolidinones; Psychometrics; Psychomotor Performance; Reference Values; Serotonin Receptor Agonists; Tryptamines	1998
The absolute bioavailability and effect of food on the pharmacokinetics of zolmitriptan in healthy volunteers. British journal of clinical pharmacology, 1998, Volume: 46, Issue:5 Topics: Adolescent; Adult; Biological Availability; Cross-Over Studies; Female; Food-Drug Interactions; Humans; Male; Middle Aged; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Tryptamines	1998
Lack of an effect of zolmitriptan (Zomig, 311C90) on psychometric task performance: results of a placebo-controlled study in healthy volunteers. Psychopharmacology, 1998, Volume: 140, Issue:4 Topics: Adolescent; Adult; Affect; Anti-Anxiety Agents; Color Perception; Cross-Over Studies; Double-Blind Method; Female; Humans; Lorazepam; Male; Mental Processes; Middle Aged; Oxazoles; Oxazolidinones; Psychometrics; Psychomotor Performance; Reaction Time; Serotonin Receptor Agonists; Tryptamines	1998
Effects of zolmitriptan (Zomig) on central serotonergic neurotransmission as assessed by active oddball auditory event-related potentials in volunteers without migraine. Cephalalgia : an international journal of headache, 1999, Volume: 19, Issue:2 Topics: Acoustic Stimulation; Adult; Double-Blind Method; Electroencephalography; Evoked Potentials, Auditory; Female; Humans; Male; Migraine Disorders; Oxazoles; Oxazolidinones; Reference Values; Serotonin Receptor Agonists; Tryptamines	1999
A comparison of the pharmacokinetics and tolerability of the novel antimigraine compound zolmitriptan in adolescents and adults. Journal of child and adolescent psychopharmacology, 1999, Volume: 9, Issue:1 Topics: Adolescent; Adult; Aged; Aging; Area Under Curve; Biotransformation; Child; Female; Half-Life; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Tryptamines	1999
The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers. British journal of clinical pharmacology, 1999, Volume: 48, Issue:2 Topics: Adult; Area Under Curve; Benzamides; Biotransformation; Blood Pressure; Cross-Over Studies; Double-Blind Method; Female; Half-Life; Humans; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines	1999
Zolmitriptan-induced growth hormone release in humans: mediation by 5-HT1D receptors? Psychopharmacology, 1999, Volume: 145, Issue:2 Topics: Adolescent; Adult; Cross-Over Studies; Double-Blind Method; Female; Human Growth Hormone; Humans; Male; Middle Aged; Oxazoles; Oxazolidinones; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	1999
Unbalanced randomization influences placebo response: scientific versus ethical issues around the use of placebo in migraine trials. Cephalalgia : an international journal of headache, 1999, Volume: 19, Issue:8 Topics: Double-Blind Method; Ethics, Medical; Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Placebos; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	1999
A long-term study to maximise migraine relief with zolmitriptan. Current medical research and opinion, 1999, Volume: 15, Issue:4 Topics: Adolescent; Adult; Aged; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Recurrence; Serotonin Receptor Agonists; Tablets; Time Factors; Tryptamines	1999
Zolmitriptan provides consistent migraine relief when used in the long-term. Current medical research and opinion, 1999, Volume: 15, Issue:4 Topics: Adolescent; Adult; Aged; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Time Factors; Tryptamines	1999
Zolmitriptan is effective for the treatment of persistent and recurrent migraine headache. Current medical research and opinion, 1999, Volume: 15, Issue:4 Topics: Adolescent; Adult; Aged; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Recurrence; Serotonin Receptor Agonists; Time Factors; Tryptamines	1999
[Oral zolmitriptan (Zomig) in the treatment of migraine crisis]. Revue medicale de la Suisse romande, 2000, Volume: 120, Issue:1 Topics: Administration, Oral; Adolescent; Adult; Humans; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Tryptamines	2000
A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine. Headache, 2000, Volume: 40, Issue:2 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Patient Satisfaction; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Treatment Outcome; Tryptamines	2000
Oral zolmitriptan is effective in the acute treatment of cluster headache. Neurology, 2000, May-09, Volume: 54, Issue:9 Topics: Acute Disease; Administration, Oral; Adult; Aged; Cluster Headache; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Oxazoles; Oxazolidinones; Pain Measurement; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2000
Comparison of the efficacy of zolmitriptan and sumatriptan: issues in migraine trial design. Cephalalgia : an international journal of headache, 2000, Volume: 20, Issue:1 Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Recurrence; Research Design; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	2000
Low dose zolmitriptan as a 5-HT neuroendocrine challenge agent in humans. Psychoneuroendocrinology, 2000, Volume: 25, Issue:6 Topics: Adult; Blood Pressure; Body Temperature; Double-Blind Method; Female; Human Growth Hormone; Humans; Hydrocortisone; Kinetics; Male; Neurosecretory Systems; Oxazoles; Oxazolidinones; Placebos; Prolactin; Serotonin Receptor Agonists; Tryptamines	2000
Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: a comparative open trial. Headache, 2000, Volume: 40, Issue:6 Topics: Administration, Oral; Cross-Over Studies; Drug Resistance; Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Retreatment; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents	2000
Preliminary studies of the pharmacokinetics and tolerability of zolmitriptan nasal spray in healthy volunteers. Journal of clinical pharmacology, 2002, Volume: 42, Issue:11 Topics: Administration, Intranasal; Administration, Oral; Adult; Analysis of Variance; Area Under Curve; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hydrogen-Ion Concentration; Male; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Tablets; Time Factors; Tryptamines	2002
Pharmacokinetics, dose proportionality, and tolerability of single and repeat doses of a nasal spray formulation of zolmitriptan in healthy volunteers. Journal of clinical pharmacology, 2002, Volume: 42, Issue:11 Topics: Administration, Intranasal; Adult; Area Under Curve; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Time Factors; Tryptamines	2002

Other Studies

49 other study(ies) available for oxazoles and zolmitriptan

Article	Year
Extending therapeutic options? Prospects for the future. European neurology, 1996, Volume: 36 Suppl 2 Topics: Cerebrovascular Circulation; Forecasting; Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Trigeminal Nerve; Tryptamines	1996
311C90 (Zolmitriptan), a novel centrally and peripheral acting oral 5-hydroxytryptamine-1D agonist: a comparison of its absorption during a migraine attack and in a migraine-free period. Cephalalgia : an international journal of headache, 1996, Volume: 16, Issue:4 Topics: Adolescent; Adult; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Recurrence; Serotonin Receptor Agonists; Time Factors; Tryptamines	1996
Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine? Pain, 1996, Volume: 67, Issue:2-3 Topics: Animals; Brain Stem; Cats; Cranial Sinuses; Dose-Response Relationship, Drug; Electric Stimulation; Electrophysiology; Evoked Potentials; Injections, Intravenous; Migraine Disorders; Neural Inhibition; Neurons; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Trigeminal Caudal Nucleus; Tryptamines	1996
311C90: patient profiles and typical case histories of migraine management. Neurology, 1997, Volume: 48, Issue:3 Suppl 3 Topics: Adult; Female; Humans; Male; Menstruation; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Time Factors; Tryptamines	1997
Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan). British journal of pharmacology, 1997, Volume: 121, Issue:2 Topics: Animals; Coronary Vessels; Dose-Response Relationship, Drug; Guinea Pigs; Heart; Humans; Male; Muscle Contraction; Oxazoles; Oxazolidinones; Rabbits; Serotonin Receptor Agonists; Trigeminal Ganglion; Tryptamines	1997
Direct evidence for central sites of action of zolmitriptan (311C90): an autoradiographic study in cat. Cephalalgia : an international journal of headache, 1997, Volume: 17, Issue:3 Topics: Animals; Autoradiography; Brain Stem; Cats; Central Nervous System; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Spinal Cord; Tryptamines	1997
Is a central action of acute antimigraine drugs essential? Cephalalgia : an international journal of headache, 1997, Volume: 17 Suppl 17 Topics: Analgesics; Animals; Brain; Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Tryptamines	1997
Measuring central action of acute antimigraine drugs in humans. Cephalalgia : an international journal of headache, 1997, Volume: 17 Suppl 17 Topics: Analgesics; Brain; Contingent Negative Variation; Electroencephalography; Evoked Potentials, Auditory; Evoked Potentials, Visual; Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Tryptamines	1997
Would any acute treatment for migraine demonstrate recurrence? Cephalalgia : an international journal of headache, 1997, Volume: 17 Suppl 17 Topics: Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	1997
Central sites of actions of zolmitriptan and sumatriptan: 5HT1B, 5HT1D and 5HT1F receptor distribution. Cephalalgia : an international journal of headache, 1997, Volume: 17, Issue:6 Topics: Central Nervous System; Humans; Oxazoles; Oxazolidinones; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	1997
Attacking migraine headache from beginning to end. Neurology, 1997, Volume: 49, Issue:5 Topics: Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Tryptamines	1997
The clinical pharmacokinetics of zolmitriptan. Cephalalgia : an international journal of headache, 1997, Volume: 17 Suppl 18 Topics: Absorption; Adult; Case-Control Studies; Female; Humans; Liver Diseases; Male; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Tissue Distribution; Tryptamines	1997
Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat. Brain : a journal of neurology, 1997, Volume: 120 ( Pt 12) Topics: Afferent Pathways; Animals; Cats; Electric Stimulation; Homocysteine; Humans; Iontophoresis; Neurons; Oxazoles; Oxazolidinones; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Spinal Cord; Sumatriptan; Trigeminal Nerve; Tryptamines	1997
Zolmitriptan receives migraine indication. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Jan-15, Volume: 55, Issue:2 Topics: Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Tryptamines	1998
Oral migraine treatment approved. The Nurse practitioner, 1998, Volume: 23, Issue:1 Topics: Administration, Oral; Contraindications; Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Rabies Vaccines; Serotonin Receptor Agonists; Tryptamines; United States; United States Food and Drug Administration	1998
A triptan too far? Journal of neurology, neurosurgery, and psychiatry, 1998, Volume: 64, Issue:2 Topics: Acute Disease; Clinical Trials as Topic; Humans; Indoles; Migraine Disorders; Oxazoles; Oxazolidinones; Piperidines; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	1998
Pharmacological analysis of the haemodynamic effects of 5-HT1B/D receptor agonists in the normotensive rat. British journal of pharmacology, 1998, Volume: 123, Issue:2 Topics: Animals; Autonomic Nervous System; Blood Pressure; Drug Interactions; Heart Rate; Hemodynamics; Male; Oxazoles; Oxazolidinones; Parasympathetic Nervous System; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines	1998
Zolmitriptan for migraine. The Medical letter on drugs and therapeutics, 1998, Feb-27, Volume: 40, Issue:1021 Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Interactions; Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Tryptamines	1998
Cortical spreading depression-associated hyperemia in rats: involvement of serotonin. Brain research, 1998, Feb-09, Volume: 783, Issue:2 Topics: Animals; Cerebrovascular Circulation; Cortical Spreading Depression; Hyperemia; Male; Migraine Disorders; Oxazoles; Oxazolidinones; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Ritanserin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tryptamines	1998
Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat. Experimental neurology, 1998, Volume: 150, Issue:1 Topics: Animals; Cats; Cerebrovascular Circulation; Cranial Sinuses; Electric Stimulation; Gene Expression Regulation; Genes, fos; Migraine Disorders; Neurons, Afferent; Nociceptors; Oxazoles; Oxazolidinones; Pain; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Synaptic Transmission; Trigeminal Caudal Nucleus; Trigeminal Nerve; Trigeminal Nucleus, Spinal; Tryptamines; Vasoconstrictor Agents	1998
It never hurts to check. Taking the time to read a label benefited this migraine sufferer. The American journal of nursing, 1998, Volume: 98, Issue:6 Topics: Adult; Contraindications; Drug Labeling; Female; Humans; Medication Errors; Migraine Disorders; Oxazoles; Oxazolidinones; Patient Education as Topic; Reading; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	1998
Effects of sumatriptan on coronary flow and left ventricular function in the isolated perfused guinea pig heart. Journal of cardiovascular pharmacology, 1998, Volume: 32, Issue:3 Topics: Animals; Coronary Circulation; Diastole; Dihydroergotamine; Endothelium, Vascular; Guinea Pigs; In Vitro Techniques; NG-Nitroarginine Methyl Ester; Oxadiazoles; Oxazoles; Oxazolidinones; Perfusion; Piperazines; Rabbits; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; Ventricular Function, Left	1998
Effects of the serotonin1B/1D receptor agonist zolmitriptan on motor cortical excitability in humans. Neurology, 1998, Volume: 51, Issue:3 Topics: Adult; Brain; Electromyography; Female; Humans; Male; Motor Cortex; Oxazoles; Oxazolidinones; Receptors, Serotonin; Serotonin Receptor Agonists; Tryptamines	1998
New "triptans" and other drugs for migraine. The Medical letter on drugs and therapeutics, 1998, Oct-09, Volume: 40, Issue:1037 Topics: Adrenergic beta-Antagonists; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Dihydroergotamine; Drug Interactions; Ergotamine; Humans; Indoles; Methysergide; Migraine Disorders; Naproxen; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Timolol; Triazoles; Tryptamines; Valproic Acid; Vasoconstrictor Agents	1998
Cranial vascular effects of zolmitriptan, a centrally active 5-HT1B/1D receptor partial agonist for the acute treatment of migraine. European journal of pharmacology, 1998, Nov-20, Volume: 361, Issue:2-3 Topics: Animals; Arteriovenous Anastomosis; Blood Flow Velocity; Carotid Arteries; Cats; Cerebral Cortex; Disease Models, Animal; Dogs; Male; Migraine Disorders; Oxazoles; Oxazolidinones; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Serotonin Receptor Agonists; Tryptamines	1998
The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats. European journal of pharmacology, 1998, Nov-27, Volume: 362, Issue:1 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Action Potentials; Analgesics; Animals; Electric Stimulation; Male; Migraine Disorders; Oxazoles; Oxazolidinones; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin Receptor Agonists; Trigeminal Caudal Nucleus; Tryptamines	1998
A triptan too far? Journal of neurology, neurosurgery, and psychiatry, 1999, Volume: 66, Issue:1 Topics: Headache; Humans; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	1999
A triptan too far? Journal of neurology, neurosurgery, and psychiatry, 1999, Volume: 66, Issue:1 Topics: Headache; Humans; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	1999
[Zolmitriptan]. Revue medicale de Bruxelles, 1998, Volume: 19, Issue:6 Topics: Chemistry, Pharmaceutical; Humans; Indoles; Migraine Disorders; Oxazoles; Oxazolidinones; Piperidines; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	1998
Headache after frequent use of serotonin agonists zolmitriptan and naratriptan. Lancet (London, England), 1999, Jan-30, Volume: 353, Issue:9150 Topics: Adult; Female; Headache; Humans; Indoles; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Piperidines; Serotonin Receptor Agonists; Tryptamines	1999
Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors. European journal of pharmacology, 1999, Mar-05, Volume: 368, Issue:2-3 Topics: Animals; Binding, Competitive; Cell Line; Cold Temperature; COS Cells; HeLa Cells; Humans; Indoles; Kinetics; Oxazoles; Oxazolidinones; Piperidines; Pyrrolidines; Radioligand Assay; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Sumatriptan; Triazoles; Tritium; Tryptamines	1999
Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques. European journal of pharmacology, 1999, May-07, Volume: 372, Issue:1 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Cardiovascular System; Coronary Vessels; Dose-Response Relationship, Drug; Gene Expression; Humans; Immunohistochemistry; In Vitro Techniques; Ketanserin; Methiothepin; Oxazoles; Oxazolidinones; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Tissue Distribution; Tryptamines; Vasoconstriction	1999
Zolmitriptan. Canadian family physician Medecin de famille canadien, 1999, Volume: 45 Topics: Drug Interactions; Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	1999
Partial agonism at serotonin 5-HT1B and dopamine D2L receptors using a luciferase reporter gene assay. European journal of pharmacology, 1999, Jun-04, Volume: 373, Issue:2-3 Topics: Animals; CHO Cells; Cricetinae; Cyclic AMP; Dihydroergotoxine; Dopamine Agonists; Genes, Reporter; Lisuride; Luciferases; Oxazoles; Oxazolidinones; Receptor, Serotonin, 5-HT1B; Receptors, Dopamine D2; Receptors, Serotonin; Recombinant Fusion Proteins; Serotonin; Serotonin Receptor Agonists; Tryptamines	1999
Drug-induced headaches. Lancet (London, England), 1999, Jul-17, Volume: 354, Issue:9174 Topics: Analgesics, Non-Narcotic; Ergotamine; Headache; Humans; Indoles; Oxazoles; Oxazolidinones; Piperidines; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	1999
Efficacy of 5HT in migraine. Cephalalgia : an international journal of headache, 1999, Volume: 19, Issue:7 Topics: Action Potentials; Animals; Cats; Cranial Sinuses; Electric Stimulation; Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; Vasoconstrictor Agents	1999
Measuring event-related potentials. Cephalalgia : an international journal of headache, 1999, Volume: 19 Suppl 24 Topics: Adult; Arousal; Contingent Negative Variation; Dexfenfluramine; Event-Related Potentials, P300; Evoked Potentials, Auditory, Brain Stem; Humans; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Tryptamines	1999
Determination of the human cytochrome P450 isoforms involved in the metabolism of zolmitriptan. Xenobiotica; the fate of foreign compounds in biological systems, 1999, Volume: 29, Issue:8 Topics: Cimetidine; Clorgyline; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Female; Humans; Isoenzymes; Ketoconazole; Liver; Male; Microsomes, Liver; Omeprazole; Oxazoles; Oxazolidinones; Recombinant Proteins; Serotonin Receptor Agonists; Theophylline; Tryptamines	1999
[Differentiated therapy of migraine attack]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 1999, Volume: 99, Issue:12 Topics: Adult; Analgesics; Antiemetics; Aspirin; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Male; Metoclopramide; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Severity of Illness Index; Treatment Outcome; Tryptamines	1999
Determination of antimigraine compounds rizatriptan, zolmitriptan, naratriptan and sumatriptan in human serum by liquid chromatography/electrospray tandem mass spectrometry. Rapid communications in mass spectrometry : RCM, 2000, Volume: 14, Issue:3 Topics: Bufotenin; Chromatography, High Pressure Liquid; Humans; Indoles; Mass Spectrometry; Migraine Disorders; Molecular Structure; Oxazoles; Oxazolidinones; Piperidines; Sensitivity and Specificity; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents	2000
Serotonin 5HT1B/1D receptor agonists abolish NMDA receptor-evoked enhancement of nitric oxide synthase activity and cGMP concentration in brain cortex slices. Cephalalgia : an international journal of headache, 1999, Volume: 19, Issue:10 Topics: Animals; Cerebral Cortex; Cyclic GMP; Excitatory Amino Acid Agonists; Male; N-Methylaspartate; Nitric Oxide Synthase; Oxazoles; Oxazolidinones; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, N-Methyl-D-Aspartate; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	1999
Auditory evoked potentials in the assessment of central nervous system effects of antimigraine drugs. Cephalalgia : an international journal of headache, 1999, Volume: 19, Issue:10 Topics: Adolescent; Adult; Cerebral Cortex; Evoked Potentials, Auditory; Female; Humans; Indoles; Male; Oxazoles; Oxazolidinones; Piperidines; Reproducibility of Results; Sample Size; Serotonin Receptor Agonists; Tryptamines	1999
Spinal cord infarction during use of zolmitriptan: a case report. Headache, 2000, Volume: 40, Issue:1 Topics: Female; Humans; Infarction; Menstruation; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Spinal Cord; Tryptamines	2000
Drug information incorrect. Canadian family physician Medecin de famille canadien, 2000, Volume: 46 Topics: Canada; Contraindications; Drug Interactions; France; Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Propranolol; Serotonin Receptor Agonists; Tryptamines; Vasodilator Agents	2000
Zolmitriptan stimulates a Ca(2+)-dependent K(+) current in C6 glioma cells stably expressing recombinant human 5-HT(1B) receptors. European journal of pharmacology, 2000, Jun-02, Volume: 397, Issue:2-3 Topics: Animals; Calcium; Dose-Response Relationship, Drug; Humans; Membrane Potentials; Oxadiazoles; Oxazoles; Oxazolidinones; Peptides; Piperazines; Potassium Channels; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Recombinant Fusion Proteins; Serotonin Antagonists; Serotonin Receptor Agonists; Tetraethylammonium; Tryptamines; Tumor Cells, Cultured	2000
Zolmitriptan reverses blink reflex changes induced during the migraine attack in humans. Neuroscience letters, 2000, Jul-28, Volume: 289, Issue:1 Topics: Adolescent; Adult; Blinking; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Sumatriptan; Trigeminal Ganglion; Tryptamines; Vasoconstrictor Agents	2000
Triptans to the rescue: effective therapy for migraine headaches in the workplace. Mayo Clinic proceedings, 2000, Volume: 75, Issue:8 Topics: Absenteeism; Adult; Cost-Benefit Analysis; Efficiency; Female; Humans; Indoles; Injections, Subcutaneous; Male; Migraine Disorders; Oxazoles; Oxazolidinones; Piperidines; Randomized Controlled Trials as Topic; Self Administration; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Workplace	2000
Identification, preparation and UHPLC determination of process-related impurity in zolmitriptan. Journal of pharmaceutical and biomedical analysis, 2012, Jan-25, Volume: 58 Topics: Chemistry Techniques, Synthetic; Chromatography, High Pressure Liquid; Drug Contamination; Limit of Detection; Magnetic Resonance Spectroscopy; Mass Spectrometry; Oxazoles; Oxazolidinones; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Tryptamines	2012
Population Pharmacokinetic Analysis of Zolmitriptan and Its Metabolite in Adults and Adolescents to Support Dose Selection in Children With Migraine. Journal of clinical pharmacology, 2017, Volume: 57, Issue:10 Topics: Administration, Intranasal; Adolescent; Adult; Body Weight; Child; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Migraine Disorders; Models, Biological; Oxazoles; Oxazolidinones; Serotonin 5-HT1 Receptor Agonists; Tryptamines; Young Adult	2017